|
⚲
|
| Keyboard |
| Nickson Philip
✚
|
|
|---|---|
| CIK # | 0001911369 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001911369] | |
| 4 | [0001911369] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Monte Rosa Therapeutics Inc | |
| Nickson Philip |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 3,155 | $15.17 | 47,861 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 126,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-02 | Grant | 28,000 | ||
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2025-01-02 | Grant | 36,000 | ||
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2025-01-02 | Grant | 161,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-06-03 | Grant | 40,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-01-02 | Grant | 109,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Grant | 123,650 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2022-03-01 | Grant | 70,600 | $0.00 |